Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma

被引:0
|
作者
Chepets, A. V. [1 ]
机构
[1] Zaporizhzhia State Med Univ, Dept Pathol Anat & Forens Med, Zaporizhzhia, Ukraine
来源
PATHOLOGIA | 2015年 / 03期
关键词
Carcinoma Of Endometrium; MMP-9; TIMP-1;
D O I
10.14739/2310-1237.2015.3.55613
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim. With the aim to determine MMP-9 and TIMP-1 expression levels in the invasive endometrioid endometrial carcinoma (EEC) cells and areas of the immunopositive cells in the center of the tumor and in the area of tumor invasion into the myometrium patho-histological, immunohistochemical and morphometric study of histological specimens of operative material of 56 women with pT1-4 stage of tumor was performed. Methods and results. It was found that MMP-9 and TIMP-1 expression occurs in 100% of invasive EEC. The MMP-9 expression level in the cytoplasm of tumor cells is high - 129.11 +/- 2.38 CUOD, which is 2,2 times more than its level in normal proliferative endometrium - 59.45 +/- 9.58 CUOD (p < 0.05). The TIMP-1 expression level is 9.58 +/- 2.68 CUOD that is 2.69 times more than the expression level of TIMP-1 in normal proliferative endometrium (3.56 +/- 0.35 CUOD, p < 0.05). MMP-9 immunopositive cells make up 50.78 +/- 0.91% of area of invasive EEC tissue section and TIMP-1 immunopositive cells make up 3.76 +/- 0.15% of area of tumor tissue section. That is statistically significantly more than in normal proliferative endometrium, which has 23.31 +/- 1.31% of MMP-9 immunopositive cells and 2.82 +/- 0.14% of TIMP-1 immunopositive cells of endometrial glands. Differences between high levels of MMP-9 in the center of EEC and in the tumor myometrial invasion zone, as well as differences between the very low expression levels of TIMP-1 in these regions of the tumor were not statistically significant. With increasing of EEC histological grade the MMP-9 and TIMP-1 expression levels significantly increase (p < 0.05). There is direct weak correlation between the MMP-9 and TIMP-1 expression levels in the cells of EEC (Pearson coefficient r = +0.31). Direct strong correlation between the expression level of MMP-9 in the tumor cells and the grade of tumor (Pearson coefficient r = +0.71) is revealed. Conclusion. The results of the study showed the increasing invasive capacity of EAE with the tumor grade increasing.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 50 条
  • [31] Serum Transforming Growth Factor-β (TGF-β), Matrix Metalloproteinase-2 (MMP-2), Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitors of Metalloproteinase (TIMP-1) Levels in Childhood Asthma
    Dogu, Figen
    Yildiran, Alisan
    Guloglu, Deniz
    Cipe, Funda Erol
    Yuksek, Mutlu
    Babacan, Emel
    Ikinciogullari, Aydan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2008, 38 (05) : 415 - 419
  • [32] ACTIVATION OF THE PRECURSOR OF MATRIX METALLOPROTEINASE-9 (PROMMP-9) COMPLEXED WITH TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) BY MATRIX METALLOPROTEINASE-3 (MMP-3)
    ITOH, Y
    OGATA, Y
    NAGASE, H
    FASEB JOURNAL, 1993, 7 (07): : A1210 - A1210
  • [33] Use of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in the pathomorphological diagnosis of carotid pathology: literature review and own observations
    Kuzyk, Yu. I.
    PATHOLOGIA, 2016, (01): : 37 - 44
  • [34] Expression of metalloproteinases MMP-1 and MMP-9 and tissue inhibitor of metalloproteinases TIMP-1 in cases of endometrial carcinoma and endometrial hyperplasia
    Wlazlak, Edyta
    Surkont, Grzegorz
    Kobos, Jozef
    Tylinski, Wieslaw
    Stetkiewicz, Tomasz
    Suzin, Jacek
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2006, 5 (06): : 363 - 366
  • [35] Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee
    Vasileios Christos Fotopoulos
    Athina Tzinia
    Matthew Tzurbakis
    Vasiliki Kalfakakou
    Stamatina Levidiotou-Stefanou
    Anastasios Georgoulis
    Knee Surgery, Sports Traumatology, Arthroscopy, 2012, 20 : 1159 - 1167
  • [36] Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression
    O'Grady, A.
    Dunne, C.
    O'Kelly, P.
    Murphy, G. M.
    Leader, M.
    Kay, E.
    HISTOPATHOLOGY, 2007, 51 (06) : 793 - 804
  • [37] Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee
    Fotopoulos, Vasileios Christos
    Tzinia, Athina
    Tzurbakis, Matthew
    Kalfakakou, Vasiliki
    Levidiotou-Stefanou, Stamatina
    Georgoulis, Anastasios
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2012, 20 (06) : 1159 - 1167
  • [38] Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma
    Babichenko, Igor I.
    Andriukhin, Mikhail I.
    Pulbere, Sergey
    Loktev, Artem
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (12): : 9090 - 9098
  • [39] Cytokine regulation of matrix metalloproteinase-9 (MMP-9) and its inhibitor (TIMP-1) in non-Hodkin's lymphomas.
    Prusinkiewicz, C
    Zhang, CL
    Brasher, P
    Urbanski, SJ
    Grogan, T
    Kossakowska, AE
    MODERN PATHOLOGY, 1998, 11 (01) : 138A - 138A
  • [40] Expression of matrix metalloproteinase MMP9 and tissue inhibitor of metalloproteinase TIMP2 in malignant salivary gland tumors
    Lewandowska, Malgorzata
    Latalska, Karolina
    Taran, Katarzyna
    Kobos, Jozef
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2013, 15 (02): : 134 - 136